Match!
Terra Slaton
University of South Carolina
41Publications
10H-index
387Citations
Publications 42
Newest
Source
Source
#1Adam D. Porath (Renown Health)
#2Sharon Clodfelter (Renown Health)
Last.Michael J. BlochH-Index: 10
view all 7 authors...
Abstract Purpose Renown Health (Reno, Nevada), a large, locally owned, not-for-profit integrated health care network, has developed an institution-wide policy to shift the treatment of deep vein thrombosis (DVT) from a short-acting anticoagulant and vitamin K antagonist to the direct oral anticoagulant rivaroxaban combined with pharmacy-directed follow-up at an outpatient anticoagulation clinic. We examined data on hospitalizations and costs pre–/post–policy change. Methods Data were obtained fr...
Source
Source
Source
Source
#1Eric M Maiese (Janssen Pharmaceutica)H-Index: 1
#2Terra SlatonH-Index: 10
Last.Chris M. KozmaH-Index: 19
view all 3 authors...
Source
#1Melissa H. RobertsH-Index: 14
#2Emmanuelle Clerisme-Beaty (Boehringer Ingelheim)H-Index: 8
Last.Douglas W. MapelH-Index: 21
view all 6 authors...
Background Chronic obstructive pulmonary disease (COPD) is often associated with recurrent hospitalizations. This study aimed to identify factors related to COPD rehospitalization.
8 CitationsSource
#1Eric M Maiese (Janssen Pharmaceutica)H-Index: 1
#2Terra SlatonH-Index: 10
Last.Chris M. KozmaH-Index: 19
view all 4 authors...
8052Background: Multiple myeloma (MM) combination therapy has been shown to convey greater efficacy compared to monotherapy (+/- steroids) in earlier lines of therapy. However, data describing real...
Source
#1Chris M. KozmaH-Index: 19
#2Terra SlatonH-Index: 10
Last.Eric M Maiese (Janssen Pharmaceutica)H-Index: 1
view all 4 authors...
Source
12345